Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt